Pharvaris N.V. (PHVS) — Stock Score Summary

Pharvaris N.V. (PHVS) has a MoatMap StockRank of 52/100 based on Quality (37/100), Value (35/100), and Momentum (65/100) factor scores. The current signal is HOLD. Pharvaris is a clinical-stage biopharmaceutical company focusing on hereditary angioedema. As a pre-revenue biotech, it is highly speculative and does not meet our quality criteria of high ROIC and established pricing power.

Pharvaris N.V. is a clinical-stage biopharmaceutical company dedicated to developing innovative oral bradykinin-B2-receptor antagonists for rare diseases, specifically hereditary angioedema (HAE). The company's competitive edge is derived from its oral drug candidates, which aim to offer convenience and improved patient experience compared to existing injectable therapies. Its success hinges on clinical trial outcomes and regulatory approvals.

Key Financial Metrics

Price$31.60
Market Cap$2.1B
P/E (Forward)-11.60
Price/Book7.53
Return on Equity-73.0%
Return on Invested Capital-62.5%
Debt/Equity0.31
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-88M

Pharvaris N.V. operates in the Biotechnology industry, part of the Healthcare sector (Switzerland).

Frequently Asked Questions

What is Pharvaris N.V.’s (PHVS) StockRank?
MoatMap’s StockRank for Pharvaris N.V. (PHVS) is 52/100, with a Hold signal. It is a composite of Quality (37), Value (35), and Momentum (65) factor ranks across MoatMap’s 19,000+ stock universe.
Does Pharvaris N.V. have an economic moat?
Pharvaris N.V. (PHVS) has a Quality factor score of 37/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Pharvaris N.V. a buy, hold, or sell?
MoatMap’s current signal for Pharvaris N.V. (PHVS) is Hold, based on a StockRank of 52/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Pharvaris N.V. in?
Pharvaris N.V. (PHVS) operates in the Healthcare sector, specifically the Biotechnology industry (Switzerland).
Browse all ranked stocksPHVS deep dive reportAI ChampionsHow we score stocksSense-check another stock